Veterinary Medicines

Enteroporc AC Lyophilisate and solvent for suspension for injection for pigs

Not authorised
  • Clostridium perfringens, type C, beta1 toxoid
  • Clostridium perfringens, type A, beta2 toxoid
  • Clostridium perfringens, type A and C, alpha toxoid
Download as PDF

Product identification

Medicine name:
Enteroporc AC Lyophilisate and solvent for suspension for injection for pigs
Enteroporc AC Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Schweine
Active substance:
  • Clostridium perfringens, type C, beta1 toxoid
  • Clostridium perfringens, type A, beta2 toxoid
  • Clostridium perfringens, type A and C, alpha toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Clostridium perfringens, type C, beta1 toxoid
  • Clostridium perfringens, type A, beta2 toxoid
  • Clostridium perfringens, type A and C, alpha toxoid
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
Package description:
  • (ID8): 1 Box with 40 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (1000.0 Dose, 2000.0 millilitre(s))
  • (ID7): 1 Box with 20 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (500.0 Dose, 1000.0 millilitre(s))
  • (ID6): 1 Box with 10 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (250.0 Dose, 500.0 millilitre(s))
  • (ID5): 1 Box with 4 Box with (1 Bottle (Glass) with 50 millilitre(s) and 1 Bottle (Glass) with 25 Dose) (200.0 millilitre(s), 100.0 Dose)
  • (ID4): 1 Box with (1 Bottle (Glass) with 25 Dose and 1 Bottle (Glass) with 50 millilitre(s)) (25.0 Dose, 50.0 millilitre(s))
  • (ID3): 1 Box with 10 Box with (1 Bottle (Glass) with 20 millilitre(s) and 1 Bottle (Glass) with 10 Dose) (200.0 millilitre(s), 100.0 Dose)
  • (ID2): 1 Box with 5 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (50.0 Dose, 100.0 millilitre(s))
  • (ID1): 1 Box with (1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)) (10.0 Dose, 20.0 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 838181
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0271/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
German (PDF)
Published on: 13/10/2022
Updated on: 4/06/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/10/2022
Updated on: 4/06/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/10/2022
Updated on: 4/06/2024
Download